ClinicalTrials.Veeva

Menu

DNA Fragmentation - Effect on Pregnancy Rate

O

Odense University Hospital

Status

Completed

Conditions

Infertility, Male

Treatments

Dietary Supplement: Punalpin
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05397314
S-20140212

Details and patient eligibility

About

The purpose of this study is to determine whether Punalpin, an antioxidant, has a positive impact on DNA fragmentation in spermatozoa in male fertility patients with increased amount of DNA fragmentation in their spermatozoa. Secondary purpose is to investigate whether there is any positive effect on the subsequent pregnancy rates from the fertility treatment.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male fertility patients with increased amount of DNA fragmentation in their spermatozoa

Exclusion criteria

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

40 participants in 2 patient groups, including a placebo group

Punalpin
Experimental group
Treatment:
Dietary Supplement: Punalpin
Placebo
Placebo Comparator group
Treatment:
Other: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems